As the 'A' in ADME, Pion specializes in the measurement of absorption related physicochemical parameters including ionization, log P, dissolution, solubility and permeability.
Early phase API-sparing fiber optic dissolution and solubility measurements can identify problems including polymorphism and salt selection as well as monitor quality during batch scale-up.
Our Double-Sink(TM) PAMPA allows researchers to conduct GIT permeability screening earlier than cellular methods for only 1/50 th of the cost. Our BBB screen is 1,000 times less costly than in situ brain perfusion measurements.
Early screening with these API-sparing methods translates into considerable savings in research resources and a more focused effort on the most promising candidates.
And for companies with limited resources, Pion Biopharma conducts absorption related physicochemical testing with our in-house experts.
Specialties
ionization, log P, dissolution, permeability, PAMPA, Caco-2, solubility, excipient screening, BCScreen
Location: United States, Massachusetts, Billerica
Employees: 51-200
Phone: +1 978-528-2020
Founded date: 1996
Investors 1
| Date | Name | Website |
| - | SFW Capita... | sfwcap.com... |
Mentions in press and media 2
| Date | Title | Description | Source |
| 10.06.2023 | NIIMBL Announces USD 4.5 Million in New Funding Opportunitie... | NEWARK, Del., June 8, 2023 — The National Institute for Innovation in Manufacturing Biopharmaceutica... | vcbay.news... |
| - | SFW Capital Partners Completes A Strategic Recapitalization ... | RYE, N.Y. and BILLERICA, Mass.,—May 20, 2021 – SFW Capital Partners, LP (“SFW”) today announced that... | sfwcap.com... |